Skip to main content
logo
Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.7680
+0.0100 (1.32%)
At close: Jul 30, 2026, 4:00 PM EDT
0.8060
+0.0380 (4.95%)
After-hours: Jul 30, 2026, 5:02 PM EDT

Rein Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
714650---
Market Cap Growth
128.75%-7.39%----
Enterprise Value
71.7442.9336.97000
Last Close Price
0.771.162.30---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.4200000.00
Net Debt / EBITDA Ratio
-0.010.060.201.070.771.73
Net Debt / FCF Ratio
-0.030.170.580.870.851.92
Quick Ratio
0.330.522.243.956.2810.19
Current Ratio
0.400.702.384.176.4610.69
Return on Equity (ROE)
-352.23%-139.87%-82.37%-26.91%-87.41%-93.33%
Return on Assets (ROA)
-199.23%-115.62%-75.57%-25.43%-78.44%-82.09%
Return on Invested Capital (ROIC)
-389.97%-180.76%-103.73%-41.52%--
Return on Capital Employed (ROCE)
-328.13%-136.07%-82.39%-27.07%-88.33%-94.42%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-29.11%-41.84%-290.09%-1.31%-2.23%-154.70%
Total Shareholder Return
-29.11%-41.84%-290.09%-1.31%-2.23%-154.70%
SEC Filings: 10-K · 10-Q